Celldex Therapeutics Inc banner

Celldex Therapeutics Inc
NASDAQ:CLDX

Watchlist Manager
Celldex Therapeutics Inc Logo
Celldex Therapeutics Inc
NASDAQ:CLDX
Watchlist
Price: 34.09 USD 0.92% Market Closed
Market Cap: $2.7B

Dividends

Celldex Therapeutics Inc
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Celldex Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Celldex Therapeutics Inc

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

CLDX Price
Celldex Therapeutics Inc

Annual Price Range
34.09
52w Low
20.01
52w High
34.55
Price Metrics
Average Annual Return -5.08%
Standard Deviation of Annual Returns 22.45%
Max Drawdown -73%
Shares Statistics
Market Capitalization 2.7B USD
Shares Outstanding 78 490 000
Percentage of Shares Shorted 10.8%

CLDX Return Decomposition
Main factors of price return

Stock Splits

CLDX's latest stock split occurred on Feb 11, 2019

The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.

Before the split, CLDX traded at 0.3919 per share. Afterward, the share price was about 4.76.

The adjusted shares began trading on Feb 11, 2019. This was stock split number 2 in CLDX's history, following the previous one in Mar 10, 2008.

Pre-Split Price
5.8785 0.3919
Post-Split Price
4.76
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett